Review



standard single-gene test platforms genmark esensor xt-8  (GenMark Diagnostics)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    GenMark Diagnostics standard single-gene test platforms genmark esensor xt-8
    Pharmacogenomic testing
    Standard Single Gene Test Platforms Genmark Esensor Xt 8, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/standard+single-gene+test+platforms+genmark+esensor+xt-8/genmark+esensor++xt+8/pmc06019555-134-51-50
    Average 90 stars, based on 1 article reviews
    standard single-gene test platforms genmark esensor xt-8 - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "Multi-site investigation of strategies for the implementation of CYP2C19 genotype-guided antiplatelet therapy"

    Article Title: Multi-site investigation of strategies for the implementation of CYP2C19 genotype-guided antiplatelet therapy

    Journal: Clinical pharmacology and therapeutics

    doi: 10.1002/cpt.1006

    Pharmacogenomic testing
    Figure Legend Snippet: Pharmacogenomic testing

    Techniques Used: TaqMan Assay

    Related Articles

    TaqMan Assay:

    Article Title: Multi-site investigation of strategies for the implementation of CYP2C19 genotype-guided antiplatelet therapy
    Article Snippet: Median genotype turnaround time (TAT), defined as each institution’s median time from genotype order to result appearing in the EHR, varied widely among institutions, from very short (1 to 5 hours with rapid testing platforms such as Spartan RX), to 1-3 days with standard single-gene test platforms in reactive models (GenMark eSensor XT-8 or custom Taqman® assays), to longer (6 to 8 days) for those institutions who used preemptive panel-based or send-out testing strategies.

    Modification:

    Article Title: Multi-site investigation of strategies for the implementation of CYP2C19 genotype-guided antiplatelet therapy
    Article Snippet: Median genotype turnaround time (TAT), defined as each institution’s median time from genotype order to result appearing in the EHR, varied widely among institutions, from very short (1 to 5 hours with rapid testing platforms such as Spartan RX), to 1-3 days with standard single-gene test platforms in reactive models (GenMark eSensor XT-8 or custom Taqman® assays), to longer (6 to 8 days) for those institutions who used preemptive panel-based or send-out testing strategies.



    Similar Products

    standard single-gene test platforms genmark esensor xt-8  (GenMark Diagnostics)
    90
    GenMark Diagnostics standard single-gene test platforms genmark esensor xt-8
    Pharmacogenomic testing
    Standard Single Gene Test Platforms Genmark Esensor Xt 8, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/standard+single-gene+test+platforms+genmark+esensor+xt-8/genmark+esensor++xt+8/pmc06019555-134-51-50
    Average 90 stars, based on 1 article reviews
    standard single-gene test platforms genmark esensor xt-8 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Pharmacogenomic testing

    Journal: Clinical pharmacology and therapeutics

    Article Title: Multi-site investigation of strategies for the implementation of CYP2C19 genotype-guided antiplatelet therapy

    doi: 10.1002/cpt.1006

    Figure Lengend Snippet: Pharmacogenomic testing

    Article Snippet: Median genotype turnaround time (TAT), defined as each institution’s median time from genotype order to result appearing in the EHR, varied widely among institutions, from very short (1 to 5 hours with rapid testing platforms such as Spartan RX), to 1-3 days with standard single-gene test platforms in reactive models (GenMark eSensor XT-8 or custom Taqman® assays), to longer (6 to 8 days) for those institutions who used preemptive panel-based or send-out testing strategies.

    Techniques: TaqMan Assay